ALPP yields 285714.29% · ABBV yields 3.06%● Live data
📍 ALPP pulled ahead of the other in Year 1
Combined, ALPP + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ALPP + ABBV for your $10,000?
Alpine 4 Holdings, Inc. a technology holding company, provides electronic contract manufacturing solutions in the United States. The company also offers automotive technologies, including 6th Sense Auto, a connected car technology that provides various advantages to management, sales, finance, and service departments in the automotive dealership industry to enhance productivity, profitability, and customer retention; and BrakeActive, a safety device that enhances vehicle's third brake light's ability to reduce or prevent a rear-end collision. In addition, it designs, fabricates, and installs dust collectors, commercial ductwork, kitchen hoods, industrial ventilation systems, machine guards, architectural work, water furnaces, and other products, as well as offers specialized spiral ductwork. Further, the company provides logistics services for various industries, such as medical, consumer electronics, energy, and disaster relief; contract manufacturing services for dietary and nutritional supplements; international contracting, fabricator, and project management services; and geospatial and 3D data services for various industries, including construction, oil/gas, mining, and quarries. It also manufacturers and sells electronic components; and designs, manufactures, and distributes commercial LED lighting and electronics, such as televisions, mounting solutions, projectors and screens, audio equipment, digital signage, mobile audio and video systems, and various wire and connecting products. The company was formerly known as Alpine 4 Technologies, Ltd. and changed its name to Alpine 4 Holdings, Inc. in March 2021. Alpine 4 Holdings, Inc. was incorporated in 2014 and is based in Phoenix, Arizona.
Full ALPP Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.